A bacterial effector blocks SUMOylation by steric occlusion of UBC9 via arginine-GlcNAcylation

Salmonella employs the T3SS-2 effector SseK1 to specifically arginine-GlcNAcylate the host SUMO E2-conjugating enzyme UBC9 at residue R17, sterically blocking SUMO binding and thereby dismantling the SUMOylation machinery to suppress antimicrobial defense and promote bacterial virulence.

The Gist

Imagine your body's immune system as a highly sophisticated security team. One of their most important tools is a set of "security tags" called SUMO. When the body detects an invader, it slaps these tags onto specific proteins to activate them, stabilize them, or move them to the right place to fight the infection. It's like putting a "DO NOT DISTURB" or "HIGH PRIORITY" sticker on a security guard's badge so they can do their job effectively.

Now, imagine a bacterial spy, Salmonella, trying to break into a bank (your cells). It knows that if the security team gets fully activated, the bank will be locked down, and the spy will be caught. So, Salmonella needs a way to disable the security team without destroying the guards themselves (which would trigger an alarm).

Here is how this paper explains the clever trick Salmonella uses, broken down into simple steps:

1. The Problem: The Security Team is Too Good

When Salmonella enters a cell, the host immediately tries to slap those SUMO tags on its defense proteins. The researchers noticed that within just a few hours, the "tagging" stopped working completely. The security guards were still there, and the "tagging machine" (the enzymes) was still present, but nothing was getting tagged.

2. The Culprit: A Specialized Spy Tool (SseK1)

The researchers played detective and found that Salmonella uses a specific weapon called SseK1. This is a protein injected by the bacteria into the cell. Think of SseK1 as a master locksmith who doesn't break the lock; instead, he jams the keyhole so the key can't turn.

3. The Target: The Master Key (UBC9)

The most important part of the tagging machine is a protein called UBC9. You can think of UBC9 as the Master Key that holds the security tag (SUMO) and sticks it onto the guards. Without UBC9, the tags can't be applied.

Usually, bacteria try to destroy the Master Key. But Salmonella is smarter. It doesn't destroy UBC9; it disables it.

4. The Trick: Glue on the Key (Arginine-GlcNAcylation)

SseK1 has a unique ability. It takes a sticky, bulky molecule (called GlcNAc) and glues it directly onto a specific spot on the Master Key (UBC9).

• The Analogy: Imagine the Master Key has a tiny, precise notch (called R17) that fits perfectly into the lock (the SUMO tag). SseK1 glues a huge, sticky gum ball right over that notch.
• The Result: The Master Key is still there, and it looks normal, but it can no longer fit into the lock. The "gum" (the modification) physically blocks the key from working. This is called steric occlusion—a fancy way of saying "blocking by size."

5. The Special Design: The "Lid"

What makes this even more impressive is that Salmonella's spy tool (SseK1) has a special C-terminal lid (a little flap at the end of the protein).

• The Analogy: Most other bacterial tools are like generic screwdrivers. But Salmonella's tool has a custom-shaped handle (the ARHVQ motif) that fits only into the Master Key's specific shape. This "lid" acts like a clamp, grabbing the Master Key and holding it in place so the glue can be applied perfectly. This is a unique evolutionary invention found only in Salmonella.

6. The Aftermath: Chaos in the Security System

Once the Master Key is jammed:

• The Tags Stop: The security guards (immune proteins like MyD88 and Hspa8) don't get their "High Priority" stickers. They become confused, inactive, or unstable.
• The Guards Fall: Some guards, like PDCD4, rely on the tags to stay safe. Without the tags, they fall apart and disappear.
• The Bank is Open: With the security system paralyzed, Salmonella can survive, multiply, and spread throughout the body.

7. The Proof: Turning the Tables

The researchers proved this by doing two things:

1. Disabling the Spy: When they used a version of Salmonella without the SseK1 tool, the bacteria were easily defeated by the host's immune system.
2. Disabling the Security: When they used a chemical to jam the host's tagging machine (mimicking what SseK1 does), the Salmonella bacteria suddenly became very strong again, even without their spy tool. This proved that the bacteria's main goal was simply to stop the tagging process.

Summary

In short, Salmonella doesn't smash the immune system's factory. Instead, it sends in a specialized agent (SseK1) that sneaks up to the Master Key (UBC9) and glues a sticky blob onto its most important part. This jams the key, stops the "security tags" from being applied, and leaves the body's defenses confused and inactive, allowing the bacteria to win the battle.

This discovery is exciting because it shows a new way bacteria fight back—not by brute force, but by precise, surgical sabotage. Understanding this could help scientists design new drugs that either block the bacterial glue or force the immune system to work even when its key is jammed.

Technical Summary

1. Problem Statement

Host cells utilize SUMOylation (the attachment of Small Ubiquitin-like Modifiers to lysine residues) as a critical post-translational modification (PTM) to regulate innate immune responses, including Toll-like receptor (TLR) signaling, inflammasome activation, and protein stability. Pathogens often evolve strategies to subvert this machinery.

• The Gap: While Salmonella enterica is known to suppress host SUMOylation, previous hypotheses suggested this occurred via microRNA-mediated silencing or transcriptional repression of SUMO-cycle enzymes (e.g., UBC9, PIAS1). However, these mechanisms cannot explain the rapid collapse of SUMOylation observed within 2–4 hours of infection, given the long half-lives (~30 hours) of these enzymes.
• The Question: What is the rapid, non-degradative mechanism Salmonella uses to dismantle the host SUMOylation machinery so quickly?

2. Methodology

The study employed a multidisciplinary approach combining genetics, structural biology, proteomics, and in vivo infection models:

• Genetic Screening: Used a library of 24 Salmonella T3SS-2 effector knockout mutants to identify the specific factor responsible for SUMOylation suppression in RAW264.7 macrophages.
• Interaction Mapping: Utilized Yeast Two-Hybrid (Y2H) screening, Co-immunoprecipitation (Co-IP), and Bio-Layer Interferometry (BLI) to identify host targets of the effector.
• Enzymatic & Structural Analysis:
  • Performed in vitro enzymatic assays to confirm arginine-GlcNAcylation.
  • Used Mass Spectrometry (MS/MS) to pinpoint the specific modification site.
  • Employed AlphaFold3 for structural modeling and MicroScale Thermophoresis (MST) to measure binding kinetics between UBC9 and SUMO.
• Proteomics: Conducted quantitative SUMOylome profiling using the WaLP-K-ε-GG enrichment strategy to map global changes in SUMOylation during infection.
• In Vivo Validation: Used C57BL/6 mice infected with wild-type (WT) and mutant strains, with pharmacological rescue experiments using the SUMOylation inhibitor 2-D08.

3. Key Contributions & Findings

A. Identification of SseK1 as the Master Regulator

• The study identified SseK1, a Type III Secretion System 2 (T3SS-2) effector, as the sole factor necessary and sufficient to suppress global SUMOylation (specifically SUMO2/3 conjugation) within hours of infection.
• Crucially, this suppression occurs without degrading or downregulating the expression of SUMO-cycle enzymes (SAE1/2, UBC9, etc.), ruling out transcriptional or degradative mechanisms.

B. Mechanism of Action: Steric Occlusion via Arginine-GlcNAcylation

• Target: SseK1 directly binds and modifies the SUMO E2-conjugating enzyme UBC9.
• Modification Site: Mass spectrometry revealed that SseK1 catalyzes the transfer of N-acetylglucosamine (GlcNAc) to Arginine 17 (R17) of UBC9.
• Structural Consequence: R17 is located at the critical interface where UBC9 non-covalently recruits SUMO. The addition of the bulky GlcNAc moiety at R17 causes steric occlusion, physically blocking the binding of SUMO to UBC9.
  • MST assays confirmed that GlcNAcylated UBC9 loses almost all binding affinity for SUMO2 and significantly reduced affinity for SUMO1.
  • This effectively "paralyzes" the SUMOylation cascade by preventing the formation of the UBC9-SUMO thioester intermediate.

C. Evolutionary Innovation: The C-Terminal Lid Domain

• Unlike other Salmonella glycosyltransferases (SseK2, SseK3) which target death domain proteins, SseK1 specifically targets UBC9.
• Structural Basis: SseK1 possesses a unique C-terminal lid domain containing an ARHVQ motif.
  • AlphaFold modeling and domain-swapping experiments showed this domain acts as a "molecular clamp," forming hydrogen bonds with UBC9 (specifically residues T35 and N31) to recruit the substrate.
  • This motif is an evolutionary innovation exclusive to the Salmonella genus, distinguishing it from homologs in E. coli or Yersinia.

D. Reprogramming of the Host SUMOylome

• Quantitative proteomics identified 303 SUMOylated proteins during infection.
• SseK1-mediated UBC9 inactivation led to the specific suppression of SUMOylation on key immune regulators:
  • MyD88 & Hspa8: Reduced SUMOylation impairs their function in TLR signaling and chaperone-mediated autophagy.
  • PDCD4: Loss of SUMOylation (which normally stabilizes proteins) leads to the degradation of this tumor suppressor and immune regulator.
• This reprogramming creates a permissive environment for bacterial survival.

E. Pathogenesis and Virulence

• Intracellular Survival: The ΔsseK1 mutant showed a severe defect in surviving within macrophages.
• Chemical Rescue: Treating macrophages with the SUMOylation inhibitor 2-D08 restored the survival of the ΔsseK1 mutant to wild-type levels, proving that the host's SUMOylation machinery is the primary defense being neutralized by SseK1.
• In Vivo Virulence: In mouse models, the ΔsseK1 strain was significantly attenuated (lower bacterial loads in liver/spleen and higher survival rates). This attenuation was reversed when mice were treated with 2-D08, confirming that SseK1 is essential for systemic virulence by disabling host SUMO defenses.

4. Significance

• Novel Mechanism of Immune Evasion: This study defines a new paradigm of "modification-mediated inactivation." Instead of destroying host enzymes (a common bacterial strategy), Salmonella uses a precise enzymatic "surgical strike" (GlcNAcylation) to sterically block the active site of a central hub (UBC9).
• Speed and Efficiency: This mechanism explains the rapid (2–4 hour) collapse of SUMOylation observed during early infection, which transcriptional silencing could not account for.
• Evolutionary Insight: The discovery of the unique ARHVQ lid domain highlights how Salmonella has evolved a specialized substrate-recruitment module to hijack a specific host pathway, distinct from its close relatives.
• Therapeutic Potential: The SseK1-UBC9 axis represents a critical vulnerability in Salmonella pathogenesis. Furthermore, understanding how SseK1 precisely modulates UBC9 could offer insights for developing novel inhibitors for inflammatory diseases or cancers where SUMOylation is dysregulated.

In summary, the paper elucidates how Salmonella employs the effector SseK1 to sterically occlude the host SUMO E2 enzyme UBC9 via arginine-GlcNAcylation, thereby dismantling the host's antimicrobial SUMOylation landscape and ensuring bacterial survival and virulence.